| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MYRIAD GENETICS INC | Director | Common Stock | 107K | $2.04M | $19.14 | Jun 30, 2022 | Direct |
| Quoin Pharmaceuticals, Ltd. | Director | Ordinary Shares | 53 | $38.80 | $0.73 | Jun 7, 2024 | Direct |
| Brooklyn ImmunoTherapeutics, Inc. | Director | Stock Option | 67K | Dec 8, 2021 | Direct | ||
| MYRIAD GENETICS INC | Director | Non-Qualified Stock Option (right to buy) | 30K | Jun 30, 2022 | Direct | ||
| Quoin Pharmaceuticals, Ltd. | Director | Share Option (Right to Buy) | 7.65K | Oct 26, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| QNRX | Quoin Pharmaceuticals, Ltd. | Jun 7, 2024 | 1 | -$217 | 4 | Jun 10, 2024 | Director |
| QNRX | Quoin Pharmaceuticals, Ltd. | Oct 26, 2023 | 1 | $0 | 4 | Oct 30, 2023 | Director |
| QNRX | Quoin Pharmaceuticals, Ltd. | Jan 1, 2023 | 0 | $0 | 3/A | Mar 7, 2023 | Director |
| MYGN | MYRIAD GENETICS INC | Jun 30, 2022 | 0 | $0 | 4 | Jun 30, 2022 | Director |
| MYGN | MYRIAD GENETICS INC | Jun 2, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | Dec 8, 2021 | 1 | $0 | 4 | Dec 10, 2021 | Director |
| MYGN | MYRIAD GENETICS INC | Aug 3, 2021 | 3 | -$281K | 4 | Aug 5, 2021 | Director |
| MYGN | MYRIAD GENETICS INC | Jun 3, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director |